Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
5
×
national blog main
boston blog main
clinical trials
boston top stories
drugs
new york blog main
alnylam pharmaceuticals
biotech
boston
new york
new york top stories
rna interference
san francisco blog main
san francisco top stories
23andme
accelerated approval
acute hepatic porphyria
aldehyde
aldeyra therapeutics
alirocumab
allergan
allergic conjunctivitis
alphabet
american academy of ophthalmology
amgen
aminolevulinic acid
analytics
big data
biomatics capital
boulder/denver blog main
bristol-myers squibb
brook byers
clinical data
digisight
drug development
dry eye disease
evercore isi
evolocumab
ge ventures
What
data
5
×
new
5
×
drug
medicine
alnylam
pharmaceuticals
rna
adds
aldeyra
analyzes
approved
based
ceo
cholesterol
cleared
closer
company
developing
devices
disclosed
disease
drugs
electronic
evidence
eye
far
fatty
fda
fighting
filing
financing
gv
health
heart
horizon
inflammation
insights
intercept
interference
kapoor
Language
Current search:
data
×
new
×
" life sciences "
×
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
With New Data, Alnylam Could Seek Speedy OK For Second RNAi Drug
@xconomy.com
5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
